Company intelligence / Profile preview

Advanced Microbubbles Inc

Newark, California, United Statesadvancedmicrobubbles.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Advanced Microbubbles has demonstrated in preclinical studies that its size-isolated, ultrasound-triggered microbubble platform can safely and transiently open the blood-brain barrier for drug delivery, improve immunotherapy efficacy in pancreatic cancer models, and enable treatment of high-risk neuroblastoma with reduced chemotoxic side effects. No clinical trial results have been reported as of May 2025.

Therapeutic areas: Oncology
Modalities: Drug delivery systems (ultrasound-triggered microbubbles)Gene therapy delivery platformsImmunotherapy enhancement (via drug delivery)
Industry: Biotech

Drug pipeline

2 assets

L-Dox

Preclinical

1 more asset in the full pipeline.

Request access →

Partnerships

IndieBio/SOSV accelerator program partnership

Beyond the preview

Go deeper on Advanced Microbubbles Inc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Microbubbles Inc.

Explore the full profile